Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Name: Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
License: Public Domain

Rima Patel

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

locally advanced triple negative breast cancer, tnbc - triple-negative breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 387169
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.